H.C. Starck has announced the appointment of Dr Michael Fooken, who will take over the research and development activities for the group in Goslar, Germany.
Dr Fooken has extensive experience in the field of research and development in the chemical industry and over the past 12 years has held various global positions within the Honeywell Group, including Head of Research for the Fine Chemicals division. Before that he spent many years in production as well as in research and development.
Dr Fooken holds more than 20 patents in the fields of energy storage materials and inorganic salts. “As an experienced expert in the field of specialty chemicals, Dr Fooken is an excellent addition to H.C. Starck, and we are very pleased to have him on board,” stated Dr Andreas Meier, President and CEO of the company. “With his scientific expertise and management experience, he will successfully drive on further advancements in our research and development activities, and thus play an important role in the overall success of the entire company.”
His predecessor, Dr Gerhard Gille, is retiring on October 31, 2012. With more than 20 years at H.C. Starck, Dr Gille played a key role in the company’s growth, thanks to his new procedures for manufacturing reaction mixtures, customized components for carbides and cermets, as well as nanoscale hard material powders.
“Under the direction of Dr Gille, many research projects were launched and carried out that made major contributions to H.C. Starck’s global success. These include the magnesium reduction of highly capacitive tantalum and niobium powders, the development of ceramic cells for SOFC technology, and the development of cathode materials for lithium-ion batteries for electric cars, to name a few,” added Dr Meier.
Posted by: Paul Whittaker, Editor ipmd.net, [email protected]